Related Experiment Video

Updated: Nov 28, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.3K

Update on SWI/SNF-related gynecologic mesenchymal neoplasms: SMARCA4-deficient uterine sarcoma and SMARCB1-deficient

Brooke E Howitt1, Andrew L Folpe2

  • 1Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.

Genes, Chromosomes & Cancer
|November 30, 2020
PubMed

Insights

This review explores how genetic alterations in SMARCA4 and SMARCB1 genes, part of the SWI/SNF complex, drive gynecologic cancers. It updates knowledge on these specific gene-deficient tumors in the uterus and vulva.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • The SWI/SNF chromatin remodeling complex plays a crucial role in gene regulation.
  • Alterations in SWI/SNF components are increasingly recognized in various cancers.
  • Specific mutations in SMARCA4 and SMARCB1 are implicated in gynecologic malignancies.

Purpose of the Study:

  • To review and update the understanding of gynecologic tumors driven by SMARCA4 or SMARCB1 mutations.
  • To focus on tumors where these genes are the primary genetic alterations.
  • To consolidate current knowledge on SMARCA4-deficient and SMARCB1-deficient uterine and vulvar tumors.

Main Methods:

  • Literature review and synthesis of existing research.
  • Focus on case studies and genetic analyses of gynecologic tumors.
  • Comparative analysis of SMARCA4- and SMARCB1-deficient tumor characteristics.

Main Results:

  • SMARCA4 and SMARCB1 are key tumor suppressors in gynecologic cancers.
  • SMARCA4-deficient and SMARCB1-deficient tumors exhibit distinct clinicopathological features.
  • Ovarian small cell carcinoma of hypercalcemic type serves as a paradigm for SWI/SNF-deficient gynecologic tumors.

Conclusions:

  • SMARCA4 and SMARCB1 mutations are critical drivers in specific gynecologic malignancies.
  • Understanding these genetic alterations is essential for diagnosis and potential therapeutic strategies.
  • Further research into SWI/SNF complex function in gynecologic oncology is warranted.
Keywords:
SMARCA4SMARCB1SWI/SNFuterine neoplasmsvulvar neoplasms

More Related Videos

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.4K
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

2.0K

Related Concept Videos

Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
3.7K
Uterus and Cervix01:18

Uterus and Cervix

The uterus, commonly called the womb, is a vital reproductive organ in females designed to provide a nurturing environment for the implantation and growth of an embryo. It is shaped like a hollow pear and positioned between the urinary bladder and the rectum. The uterus's structure allows it to support and protect a developing fetus throughout pregnancy.
The uterus is securely anchored within the pelvic cavity by paired broad ligaments on either side. It is further stabilized by three pairs...
3.1K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K